Clinical Trial Update: Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating donor mesenchymal stem cell infusions for acute or chronic graft-versus-host disease after donor stem cell transplant has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Donor Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Cancer | Phase 1 | Status: COMPLETED